Published in Transplant Proc on February 01, 1993
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Paediatric lung transplantation: the agony and the ecstasy. Thorax (1994) 0.90
Interaction of antibody with Forssman antigen in guinea pigs. A mechanism of adaptation to antibody- and complement-mediated injury. Am J Pathol (1995) 0.83
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet (1999) 5.15
West Nile virus infection in birds and mosquitoes, New York State, 2000. Emerg Infect Dis (2001) 4.27
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Availability of transplantable organs from brain stem dead donors in intensive care units. BMJ (1991) 2.84
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Rapamycin for immunosuppression in organ allografting. Lancet (1989) 2.51
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med (1991) 2.45
Organs for transplantation. BMJ (1989) 2.42
Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet (1991) 2.30
Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
Xenografting: probability, possibility, or pipe dream? Lancet (1993) 2.08
West Nile virus isolates from mosquitoes in New York and New Jersey, 1999. Emerg Infect Dis (2001) 2.05
Prospective study of quality of life before and after coronary artery bypass grafting. BMJ (1991) 2.03
Cyclosporin A: preliminary observations in dogs with pancreatic duodenal allografts and patients with cadaveric renal transplants. Transplant Proc (1979) 1.94
The generation of transgenic pigs as potential organ donors for humans. Nat Med (1995) 1.86
Damage to porcine islets of Langerhans after exposure to human blood in vitro, or after intraportal transplantation to cynomologus monkeys: protective effects of sCR1 and heparin. Transplantation (2000) 1.83
Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol (1989) 1.78
A high-resolution NMR probe in which the coil and preamplifier are cooled with liquid helium. 1984. J Magn Reson (2011) 1.75
Cyclosporin A: an immunosuppressive agent preferentially active against proliferating T cells. Transplantation (1979) 1.73
Heart-lung transplantation for cystic fibrosis. Lancet (1988) 1.70
Stomach as source of bacteria colonising respiratory tract during artificial ventilation. Lancet (1978) 1.69
Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant (1998) 1.63
Human babesiosis in New York State: an epidemiological description of 136 cases. Clin Infect Dis (1992) 1.61
The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest (1990) 1.60
Long-term treatment of primary pulmonary hypertension with continuous intravenous epoprostenol (prostacyclin). Lancet (1984) 1.59
Haemodynamic correction in multiorgan donation. Lancet (1992) 1.52
Umbilicoplasty: the construction of a new umbilicus and correction of umbilical stenosis without external scars. Plast Reconstr Surg (1996) 1.51
Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation. J Heart Lung Transplant (1993) 1.47
Implementation of a proficiency testing program for Lyme disease in New York State. Arch Pathol Lab Med (1994) 1.42
Diagnosis of early cardiac transplant rejection by fall in evoked T wave amplitude measured using an externalized QT driven rate responsive pacemaker. Pacing Clin Electrophysiol (1991) 1.41
Trends in sexually transmitted infections (other than HIV) in older people: analysis of data from an enhanced surveillance system. Sex Transm Infect (2008) 1.41
Surveillance of sexually transmitted infections in the West Midlands using anonymised individual patient datasets from genitourinary medicine clinics. Commun Dis Public Health (2004) 1.40
Cyclosporin A and its analogues as modifiers of adriamycin and vincristine resistance in a multi-drug resistant human lung cancer cell line. Br J Cancer (1987) 1.40
Is the secretion of atrial natriuretic peptide in man under neural control? Eur Heart J (2000) 1.39
Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med (1992) 1.38
A prospective randomized trial of complete atrioventricular transplantation versus ventricular transplantation with atrioplasty. J Heart Lung Transplant (1999) 1.38
Use of lung biopsies in lung transplant recipients. Transplantation (1990) 1.37
Heart and lung transplantation in patients with end stage lung disease. Br Med J (Clin Res Ed) (1987) 1.37
Transbronchial lung biopsy for the diagnosis of rejection in heart-lung transplant patients. Transplantation (1988) 1.35
Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc (1991) 1.33
Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease. Transplantation (1991) 1.27
West Nile virus: a case study in how NY State Health Information infrastructure facilitates preparation and response to disease outbreaks. J Public Health Manag Pract (2001) 1.27
Mode of action of cyclosporin A: a new immunosuppressive agent. Transplant Proc (1979) 1.26
Incidence and aetiology of a raised hemidiaphragm after cardiopulmonary bypass. Thorax (1985) 1.25
Prospective study of health related quality of life before and after coronary artery bypass grafting: outcome at five years. Heart (1999) 1.25
Treatment of primary pulmonary hypertension intravenous epoprostenol (prostacyclin). Br Heart J (1987) 1.24
Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer (2000) 1.23
FK-506 in experimental renal allografts. Transplant Proc (1987) 1.23
Early experience of heart-lung transplantation. Arch Dis Child (1989) 1.20
Structure of the bacteriophage lambda Ser/Thr protein phosphatase with sulfate ion bound in two coordination modes. Biochemistry (2000) 1.20
Long-term survival of nonhuman primates receiving life-supporting transgenic porcine kidney xenografts. Transplantation (2000) 1.19
Occupational risk of Lyme disease in endemic areas of New York State. Ann N Y Acad Sci (1988) 1.18
Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J (1993) 1.17
Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries. Eur J Pharmacol (1989) 1.17
Immunohistochemical demonstration of human cardiac innervation before and after transplantation. Circ Res (1990) 1.16
Transforming the "unacceptable" donor: outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant (1995) 1.16
Cyclosporin-A in clinical organ grafting. Transplant Proc (1981) 1.16
Prospective study comparing quality of life before and after heart transplantation. Transplant Proc (1990) 1.15
Toxoplasmosis in cardiac transplantation. Br Med J (Clin Res Ed) (1986) 1.15
Lyme disease in New York State: spatial pattern at a regional scale. Am J Trop Med Hyg (2001) 1.14
Antiretroviral drug concentrations in semen of HIV-infected men: differential penetration of indinavir, ritonavir and saquinavir. J Antimicrob Chemother (2001) 1.14
Selection and procurement of combined heart and lung grafts for transplantation. J Thorac Cardiovasc Surg (1988) 1.14
Concentrations of nevirapine, lamivudine and stavudine in semen of HIV-1-infected men. AIDS (2000) 1.14
Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation (1991) 1.13
Significance of donor transmitted disease in cardiac transplantation. J Heart Transplant (1985) 1.13
Selection and procurement of hearts for transplantation. Br Med J (Clin Res Ed) (1984) 1.13
Clinical pharmacology and safety evaluation of Timentin. Am J Med (1985) 1.12
Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis (1989) 1.11
Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol (1990) 1.10
Heart lung transplantation in a patient with end stage lung disease due to common variable immunodeficiency. Thorax (1998) 1.10
Serosurvey for human babesiosis in New York. J Infect Dis (1980) 1.10
Heterotopic heart transplantation in the rat receiving FK-506. Transplant Proc (1987) 1.10
Transbronchial biopsies in children after heart-lung transplantation. Pediatrics (1990) 1.09
Life-supporting human complement regulator decay accelerating factor transgenic pig liver xenograft maintains the metabolic function and coagulation in the nonhuman primate for up to 8 days. Transplantation (2000) 1.07
Transplantation of liver, heart, and lungs for primary biliary cirrhosis and primary pulmonary hypertension. Lancet (1987) 1.07
Heart-lung transplantation for end-stage respiratory disease in patients with cystic fibrosis at Papworth Hospital. J Heart Lung Transplant (1994) 1.06
Three-month survival of HDAFF transgenic pig hearts transplanted into primates. Transplant Proc (1999) 1.06
Heart-lung transplantation for cystic fibrosis. 1: Assessment. Arch Dis Child (1991) 1.05
Poor penetration of the male genital tract by HIV-1 protease inhibitors. AIDS (1999) 1.05
Cytomegalovirus infections in heart and heart and lung transplant recipients. J Clin Pathol (1988) 1.05
The importance of cytomegalovirus in heart-lung transplant recipients. Chest (1989) 1.04
Seroprevalence and seroconversion for tick-borne diseases in a high-risk population in the northeast United States. Am J Med (1999) 1.04
Physiological aspects of pig-to-primate renal xenotransplantation. Kidney Int (2001) 1.03
Diagnosis and treatment of allograft rejection in heart-lung transplant recipients. J Thorac Cardiovasc Surg (1983) 1.03
Reactivity of fluoride dentifrices with artificial caries. I. Effects on early lesions: F uptake, surface hardening and remineralization. Caries Res (1987) 1.02
Heart-lung transplantation: better use of resources. Am J Med (1988) 1.02
The use of Cyclosporin A immunosuppression in organ grafting. Immunol Rev (1982) 1.02
The acute abdomen following cardiopulmonary bypass surgery. Br J Surg (1980) 1.02
Heart-lung transplantation for cystic fibrosis. 2: Outcome. Arch Dis Child (1991) 1.01
Prolonged survival of hamster to rat heart xenografts with cyclophosphamide therapy. Transplant Proc (1992) 1.01
Overexpression of cardiac I-kappaBalpha prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol (2001) 1.01
Characterization of pigs transgenic for human decay-accelerating factor. Transplantation (1997) 1.01